James Costello
Concepts (443)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder Neoplasms | 12 | 2024 | 252 | 2.800 |
Why?
| | Computational Biology | 11 | 2025 | 644 | 2.160 |
Why?
| | Cisplatin | 4 | 2024 | 320 | 1.580 |
Why?
| | Drug Resistance, Neoplasm | 8 | 2024 | 801 | 1.510 |
Why?
| | Gene Expression Profiling | 11 | 2025 | 1774 | 1.470 |
Why?
| | Algorithms | 14 | 2025 | 1704 | 1.330 |
Why?
| | Prostatic Neoplasms | 5 | 2025 | 1043 | 1.300 |
Why?
| | Down Syndrome | 4 | 2025 | 496 | 1.260 |
Why?
| | Antineoplastic Agents | 9 | 2024 | 2129 | 1.110 |
Why?
| | Cell Line, Tumor | 21 | 2025 | 3412 | 0.950 |
Why?
| | Systems Biology | 1 | 2025 | 67 | 0.910 |
Why?
| | Biomarkers, Tumor | 6 | 2025 | 1276 | 0.850 |
Why?
| | Transcriptome | 8 | 2024 | 971 | 0.850 |
Why?
| | Gene Regulatory Networks | 6 | 2023 | 305 | 0.820 |
Why?
| | Rectal Neoplasms | 2 | 2023 | 149 | 0.800 |
Why?
| | Crowdsourcing | 5 | 2023 | 17 | 0.750 |
Why?
| | Software | 3 | 2025 | 665 | 0.740 |
Why?
| | Sarcoma | 1 | 2024 | 188 | 0.730 |
Why?
| | Neoplasms | 9 | 2024 | 2671 | 0.730 |
Why?
| | Computer Simulation | 5 | 2018 | 978 | 0.730 |
Why?
| | Premature Birth | 2 | 2023 | 333 | 0.710 |
Why?
| | Hot Temperature | 1 | 2024 | 391 | 0.710 |
Why?
| | Neoadjuvant Therapy | 2 | 2020 | 404 | 0.710 |
Why?
| | Breast Neoplasms | 7 | 2025 | 2253 | 0.690 |
Why?
| | Gene Expression Regulation, Neoplastic | 15 | 2025 | 1396 | 0.690 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2021 | 43 | 0.680 |
Why?
| | Blood Proteins | 1 | 2021 | 252 | 0.620 |
Why?
| | MutS Homolog 2 Protein | 1 | 2018 | 15 | 0.610 |
Why?
| | Pre-Eclampsia | 1 | 2021 | 190 | 0.600 |
Why?
| | Genomics | 7 | 2024 | 795 | 0.600 |
Why?
| | Chromosomes, Human | 1 | 2018 | 44 | 0.590 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 179 | 0.590 |
Why?
| | Fluorescence | 1 | 2018 | 160 | 0.570 |
Why?
| | Gestational Age | 1 | 2021 | 910 | 0.560 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 160 | 0.560 |
Why?
| | Tripartite Motif Proteins | 1 | 2017 | 41 | 0.550 |
Why?
| | Transcription Factors | 4 | 2022 | 1719 | 0.550 |
Why?
| | CRISPR-Cas Systems | 1 | 2018 | 125 | 0.540 |
Why?
| | Models, Biological | 4 | 2018 | 1783 | 0.540 |
Why?
| | Humans | 71 | 2025 | 137585 | 0.540 |
Why?
| | Metabolic Networks and Pathways | 1 | 2018 | 180 | 0.540 |
Why?
| | Genetic Loci | 1 | 2018 | 288 | 0.530 |
Why?
| | Homeodomain Proteins | 5 | 2023 | 506 | 0.510 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 175 | 0.500 |
Why?
| | Body Mass Index | 1 | 2025 | 2389 | 0.500 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 1692 | 0.480 |
Why?
| | Telomerase | 4 | 2020 | 250 | 0.440 |
Why?
| | MAP Kinase Kinase Kinases | 3 | 2021 | 73 | 0.440 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 752 | 0.430 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2025 | 202 | 0.430 |
Why?
| | Cholangiocarcinoma | 2 | 2025 | 104 | 0.410 |
Why?
| | Neoplasm Recurrence, Local | 5 | 2025 | 1079 | 0.410 |
Why?
| | Bile Duct Neoplasms | 2 | 2025 | 124 | 0.410 |
Why?
| | Lung Neoplasms | 4 | 2025 | 2526 | 0.400 |
Why?
| | Competitive Behavior | 1 | 2013 | 43 | 0.400 |
Why?
| | Oligonucleotide Array Sequence Analysis | 7 | 2016 | 767 | 0.390 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2025 | 44 | 0.380 |
Why?
| | DNA-Binding Proteins | 6 | 2022 | 1502 | 0.380 |
Why?
| | Receptors, Androgen | 3 | 2021 | 150 | 0.380 |
Why?
| | Obesity | 1 | 2025 | 2992 | 0.360 |
Why?
| | Animals | 32 | 2025 | 36940 | 0.360 |
Why?
| | Carcinoma, Transitional Cell | 3 | 2017 | 71 | 0.350 |
Why?
| | Cooperative Behavior | 2 | 2016 | 451 | 0.350 |
Why?
| | Pancreatic Neoplasms | 3 | 2024 | 938 | 0.340 |
Why?
| | Drosophila | 3 | 2008 | 154 | 0.340 |
Why?
| | Radiosurgery | 2 | 2024 | 344 | 0.330 |
Why?
| | Biomedical Research | 2 | 2016 | 692 | 0.330 |
Why?
| | Rhabdomyosarcoma | 2 | 2022 | 72 | 0.330 |
Why?
| | Mutation | 8 | 2025 | 3958 | 0.330 |
Why?
| | Neoplasm Metastasis | 7 | 2025 | 658 | 0.330 |
Why?
| | Cadherins | 3 | 2024 | 206 | 0.320 |
Why?
| | Protein Interaction Mapping | 1 | 2009 | 109 | 0.300 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2023 | 289 | 0.300 |
Why?
| | Zebrafish Proteins | 2 | 2022 | 288 | 0.300 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2020 | 172 | 0.280 |
Why?
| | Mice | 20 | 2025 | 17787 | 0.280 |
Why?
| | Aminopeptidases | 2 | 2024 | 18 | 0.280 |
Why?
| | Xenograft Model Antitumor Assays | 4 | 2024 | 872 | 0.270 |
Why?
| | Drosophila melanogaster | 1 | 2009 | 233 | 0.270 |
Why?
| | Databases, Genetic | 3 | 2018 | 237 | 0.270 |
Why?
| | DNA Helicases | 2 | 2021 | 145 | 0.260 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 2 | 2017 | 51 | 0.260 |
Why?
| | Adenocarcinoma | 2 | 2024 | 940 | 0.260 |
Why?
| | Magnetic Resonance Imaging | 3 | 2024 | 3566 | 0.250 |
Why?
| | Signal Transduction | 8 | 2025 | 5079 | 0.240 |
Why?
| | Promoter Regions, Genetic | 6 | 2021 | 1250 | 0.230 |
Why?
| | Oncogene Proteins, Fusion | 3 | 2023 | 215 | 0.230 |
Why?
| | Chemokine CCL2 | 1 | 2025 | 115 | 0.230 |
Why?
| | Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2025 | 41 | 0.230 |
Why?
| | Orthomyxoviridae Infections | 1 | 2025 | 67 | 0.230 |
Why?
| | Meta-Analysis as Topic | 2 | 2023 | 186 | 0.220 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 209 | 0.220 |
Why?
| | Epigenesis, Genetic | 3 | 2020 | 660 | 0.220 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2024 | 11 | 0.220 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2025 | 115 | 0.210 |
Why?
| | Cell Proliferation | 9 | 2025 | 2475 | 0.210 |
Why?
| | Female | 24 | 2025 | 73304 | 0.200 |
Why?
| | Organoids | 1 | 2024 | 112 | 0.200 |
Why?
| | Datasets as Topic | 1 | 2023 | 121 | 0.200 |
Why?
| | Rectum | 2 | 2023 | 185 | 0.200 |
Why?
| | Endometrial Neoplasms | 1 | 2025 | 201 | 0.200 |
Why?
| | Neuroendocrine Tumors | 1 | 2024 | 116 | 0.200 |
Why?
| | Proteomics | 3 | 2021 | 1111 | 0.190 |
Why?
| | Radiation Dosage | 1 | 2024 | 179 | 0.190 |
Why?
| | Nuclear Proteins | 2 | 2020 | 712 | 0.190 |
Why?
| | MDS1 and EVI1 Complex Locus Protein | 1 | 2022 | 8 | 0.190 |
Why?
| | Indoles | 1 | 2025 | 412 | 0.190 |
Why?
| | Sarcoma, Ewing | 1 | 2023 | 97 | 0.190 |
Why?
| | Molecular Targeted Therapy | 1 | 2025 | 411 | 0.190 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2025 | 900 | 0.190 |
Why?
| | Interleukin-13 Receptor alpha2 Subunit | 1 | 2021 | 6 | 0.190 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 449 | 0.180 |
Why?
| | Melanoma | 2 | 2023 | 760 | 0.180 |
Why?
| | Neoplasm Invasiveness | 3 | 2018 | 510 | 0.180 |
Why?
| | ROC Curve | 2 | 2021 | 554 | 0.180 |
Why?
| | Muscle Development | 1 | 2022 | 111 | 0.180 |
Why?
| | NF-kappa B | 1 | 2025 | 691 | 0.180 |
Why?
| | ADAM10 Protein | 1 | 2021 | 30 | 0.170 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2023 | 224 | 0.170 |
Why?
| | Gamma Rays | 1 | 2021 | 57 | 0.170 |
Why?
| | Asymptomatic Diseases | 1 | 2021 | 89 | 0.170 |
Why?
| | Gene Ontology | 1 | 2020 | 53 | 0.170 |
Why?
| | Carcinoma, Lobular | 1 | 2021 | 49 | 0.170 |
Why?
| | Receptors, CCR2 | 1 | 2020 | 40 | 0.170 |
Why?
| | PAX3 Transcription Factor | 1 | 2020 | 17 | 0.170 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2020 | 25 | 0.170 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2021 | 80 | 0.170 |
Why?
| | Forkhead Box Protein O1 | 1 | 2020 | 33 | 0.170 |
Why?
| | Watchful Waiting | 1 | 2020 | 81 | 0.170 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2020 | 63 | 0.170 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 62 | 0.160 |
Why?
| | Wnt Signaling Pathway | 1 | 2022 | 192 | 0.160 |
Why?
| | Radiation Injuries | 1 | 2021 | 145 | 0.160 |
Why?
| | Receptors, Interferon | 1 | 2019 | 52 | 0.160 |
Why?
| | Homologous Recombination | 1 | 2019 | 28 | 0.160 |
Why?
| | Tumor Microenvironment | 2 | 2020 | 674 | 0.160 |
Why?
| | Small Molecule Libraries | 1 | 2020 | 94 | 0.160 |
Why?
| | Discoidin Domain Receptor 2 | 1 | 2019 | 5 | 0.150 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2020 | 389 | 0.150 |
Why?
| | RNA Interference | 1 | 2021 | 469 | 0.150 |
Why?
| | Cytokines | 2 | 2024 | 2085 | 0.150 |
Why?
| | Trisomy | 1 | 2019 | 80 | 0.150 |
Why?
| | Cell Differentiation | 3 | 2022 | 1991 | 0.150 |
Why?
| | Dasatinib | 1 | 2019 | 54 | 0.150 |
Why?
| | Kynurenine | 1 | 2019 | 114 | 0.150 |
Why?
| | Immunotherapy | 2 | 2025 | 641 | 0.150 |
Why?
| | Chloroquine | 1 | 2018 | 54 | 0.150 |
Why?
| | Prognosis | 7 | 2021 | 4030 | 0.150 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 62 | 0.150 |
Why?
| | Receptors, Estrogen | 1 | 2021 | 436 | 0.140 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3284 | 0.140 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 134 | 0.140 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 434 | 0.140 |
Why?
| | Molecular Conformation | 1 | 2018 | 145 | 0.140 |
Why?
| | Macrolides | 1 | 2018 | 65 | 0.140 |
Why?
| | Neoplasms, Experimental | 1 | 2019 | 176 | 0.140 |
Why?
| | Fibrosis | 1 | 2021 | 552 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 430 | 0.140 |
Why?
| | Microbiota | 2 | 2023 | 762 | 0.140 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 227 | 0.140 |
Why?
| | Monte Carlo Method | 1 | 2018 | 148 | 0.140 |
Why?
| | Lysosomes | 1 | 2018 | 141 | 0.140 |
Why?
| | Histone Code | 1 | 2017 | 34 | 0.140 |
Why?
| | Probability | 1 | 2018 | 304 | 0.140 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 617 | 0.130 |
Why?
| | Immunity, Cellular | 1 | 2019 | 268 | 0.130 |
Why?
| | Machine Learning | 2 | 2022 | 493 | 0.130 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 455 | 0.130 |
Why?
| | Cell Death | 1 | 2018 | 374 | 0.130 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 249 | 0.130 |
Why?
| | Data Interpretation, Statistical | 2 | 2009 | 363 | 0.130 |
Why?
| | Histidine Kinase | 1 | 2016 | 34 | 0.130 |
Why?
| | CD24 Antigen | 1 | 2016 | 20 | 0.130 |
Why?
| | DNA Damage | 1 | 2019 | 420 | 0.130 |
Why?
| | YY1 Transcription Factor | 1 | 2016 | 25 | 0.130 |
Why?
| | Nomograms | 1 | 2016 | 54 | 0.130 |
Why?
| | Urologic Neoplasms | 1 | 2016 | 31 | 0.130 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 217 | 0.120 |
Why?
| | Transcriptional Activation | 1 | 2018 | 378 | 0.120 |
Why?
| | Organizational Innovation | 2 | 2016 | 140 | 0.120 |
Why?
| | Sulfonamides | 1 | 2020 | 513 | 0.120 |
Why?
| | Male | 12 | 2025 | 67762 | 0.120 |
Why?
| | Deoxycytidine | 1 | 2017 | 179 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 168 | 0.120 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 365 | 0.120 |
Why?
| | DNA Methylation | 2 | 2017 | 643 | 0.120 |
Why?
| | Genetic Heterogeneity | 1 | 2015 | 59 | 0.120 |
Why?
| | rho Guanine Nucleotide Dissociation Inhibitor beta | 1 | 2014 | 4 | 0.120 |
Why?
| | Up-Regulation | 1 | 2018 | 843 | 0.120 |
Why?
| | Bayes Theorem | 3 | 2023 | 405 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 596 | 0.110 |
Why?
| | Telomere Homeostasis | 1 | 2015 | 34 | 0.110 |
Why?
| | Alleles | 1 | 2017 | 891 | 0.110 |
Why?
| | Survival Rate | 4 | 2021 | 1972 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 399 | 0.110 |
Why?
| | Histone Demethylases | 1 | 2014 | 32 | 0.110 |
Why?
| | Ovarian Neoplasms | 1 | 2020 | 565 | 0.110 |
Why?
| | rho GTP-Binding Proteins | 1 | 2014 | 60 | 0.110 |
Why?
| | Membrane Proteins | 1 | 2021 | 1164 | 0.110 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2014 | 48 | 0.110 |
Why?
| | Transcription, Genetic | 3 | 2017 | 1457 | 0.110 |
Why?
| | Ornithine Decarboxylase Inhibitors | 1 | 2013 | 3 | 0.110 |
Why?
| | Anabolic Agents | 1 | 2013 | 12 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 1 | 2024 | 2691 | 0.110 |
Why?
| | Phylogeny | 3 | 2023 | 904 | 0.110 |
Why?
| | Models, Theoretical | 1 | 2017 | 578 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2018 | 718 | 0.110 |
Why?
| | Drug Synergism | 1 | 2014 | 382 | 0.110 |
Why?
| | International Cooperation | 1 | 2014 | 198 | 0.110 |
Why?
| | High-Throughput Screening Assays | 1 | 2015 | 158 | 0.110 |
Why?
| | Organ Sparing Treatments | 1 | 2013 | 34 | 0.110 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2844 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2022 | 860 | 0.110 |
Why?
| | Microsatellite Repeats | 1 | 2014 | 168 | 0.110 |
Why?
| | Epigenomics | 1 | 2014 | 115 | 0.100 |
Why?
| | Phenotype | 2 | 2020 | 3196 | 0.100 |
Why?
| | Drug Combinations | 1 | 2014 | 343 | 0.100 |
Why?
| | Databases, Protein | 2 | 2014 | 85 | 0.100 |
Why?
| | Neoplasm Staging | 3 | 2024 | 1389 | 0.100 |
Why?
| | Infant, Newborn | 2 | 2023 | 6079 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 1 | 2022 | 1167 | 0.100 |
Why?
| | Models, Molecular | 1 | 2018 | 1570 | 0.100 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2020 | 630 | 0.100 |
Why?
| | Cluster Analysis | 2 | 2016 | 499 | 0.100 |
Why?
| | Superoxides | 1 | 2013 | 202 | 0.100 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2012 | 47 | 0.100 |
Why?
| | Integrins | 2 | 2023 | 95 | 0.100 |
Why?
| | Models, Statistical | 1 | 2016 | 669 | 0.100 |
Why?
| | Prostate | 1 | 2013 | 175 | 0.100 |
Why?
| | Community-Institutional Relations | 1 | 2013 | 98 | 0.100 |
Why?
| | Brain Neoplasms | 1 | 2021 | 1238 | 0.090 |
Why?
| | Lung | 1 | 2025 | 4060 | 0.090 |
Why?
| | Biomarkers | 2 | 2021 | 4149 | 0.090 |
Why?
| | Pregnancy | 2 | 2023 | 6763 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 327 | 0.090 |
Why?
| | Apoptosis | 3 | 2021 | 2553 | 0.090 |
Why?
| | Genome-Wide Association Study | 1 | 2018 | 1431 | 0.090 |
Why?
| | Genome, Insect | 2 | 2009 | 23 | 0.090 |
Why?
| | Alternative Splicing | 1 | 2013 | 229 | 0.090 |
Why?
| | B-Lymphocytes | 2 | 2014 | 847 | 0.090 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 267 | 0.090 |
Why?
| | Saccharomyces cerevisiae | 3 | 2012 | 557 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2020 | 10811 | 0.080 |
Why?
| | MCF-7 Cells | 2 | 2021 | 124 | 0.080 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5757 | 0.080 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 622 | 0.080 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 840 | 0.080 |
Why?
| | Horns | 1 | 2009 | 1 | 0.080 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 406 | 0.080 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2012 | 328 | 0.080 |
Why?
| | Pseudogenes | 1 | 2009 | 18 | 0.080 |
Why?
| | Expressed Sequence Tags | 1 | 2009 | 42 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2426 | 0.080 |
Why?
| | Testosterone | 1 | 2013 | 409 | 0.080 |
Why?
| | Double-Blind Method | 2 | 2025 | 1993 | 0.080 |
Why?
| | Systems Integration | 1 | 2009 | 37 | 0.080 |
Why?
| | Coleoptera | 1 | 2009 | 28 | 0.080 |
Why?
| | Drug Discovery | 2 | 2022 | 142 | 0.080 |
Why?
| | Models, Genetic | 2 | 2009 | 600 | 0.080 |
Why?
| | Inflammation | 1 | 2020 | 2837 | 0.080 |
Why?
| | Genes, Fungal | 1 | 2009 | 52 | 0.080 |
Why?
| | Stem Cells | 1 | 2013 | 594 | 0.080 |
Why?
| | Adult | 5 | 2025 | 37929 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2021 | 955 | 0.070 |
Why?
| | Genetic Diseases, Inborn | 1 | 2008 | 44 | 0.070 |
Why?
| | Genes, Insect | 1 | 2007 | 22 | 0.070 |
Why?
| | Gene Deletion | 1 | 2009 | 391 | 0.070 |
Why?
| | Aged | 6 | 2025 | 23961 | 0.070 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1236 | 0.070 |
Why?
| | Disease | 1 | 2008 | 98 | 0.070 |
Why?
| | BRCA1 Protein | 2 | 2020 | 76 | 0.070 |
Why?
| | Zebrafish | 2 | 2022 | 499 | 0.070 |
Why?
| | Genetics, Population | 1 | 2008 | 214 | 0.070 |
Why?
| | Genome, Human | 1 | 2009 | 425 | 0.070 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2025 | 1091 | 0.070 |
Why?
| | Mitochondria | 1 | 2013 | 948 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2013 | 1317 | 0.060 |
Why?
| | Prednisone | 2 | 2017 | 240 | 0.060 |
Why?
| | Selection, Genetic | 1 | 2008 | 273 | 0.060 |
Why?
| | Maintenance Chemotherapy | 1 | 2025 | 35 | 0.060 |
Why?
| | Chromatin | 2 | 2022 | 519 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2020 | 5131 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1996 | 0.060 |
Why?
| | Cell Line | 3 | 2019 | 2847 | 0.060 |
Why?
| | Base Sequence | 3 | 2017 | 2181 | 0.050 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2024 | 76 | 0.050 |
Why?
| | Cell Movement | 2 | 2021 | 967 | 0.050 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 1 | 2023 | 25 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2007 | 493 | 0.050 |
Why?
| | RNA-Binding Protein EWS | 1 | 2023 | 26 | 0.050 |
Why?
| | BCG Vaccine | 1 | 2023 | 24 | 0.050 |
Why?
| | Internet | 1 | 2008 | 655 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2016 | 4193 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2013 | 1809 | 0.050 |
Why?
| | Biological Assay | 1 | 2023 | 124 | 0.050 |
Why?
| | Mice, Nude | 2 | 2016 | 698 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2224 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2024 | 310 | 0.050 |
Why?
| | Pituitary Neoplasms | 1 | 2024 | 190 | 0.050 |
Why?
| | Myogenin | 1 | 2022 | 16 | 0.050 |
Why?
| | MyoD Protein | 1 | 2022 | 35 | 0.050 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2022 | 22 | 0.050 |
Why?
| | Proteins | 1 | 2008 | 1009 | 0.050 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 226 | 0.050 |
Why?
| | Vagina | 1 | 2023 | 187 | 0.050 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2022 | 91 | 0.050 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2023 | 153 | 0.050 |
Why?
| | Cell Lineage | 2 | 2013 | 350 | 0.050 |
Why?
| | Middle Aged | 5 | 2025 | 33479 | 0.050 |
Why?
| | Chondrogenesis | 1 | 2022 | 83 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2025 | 1142 | 0.040 |
Why?
| | Contrast Media | 1 | 2024 | 467 | 0.040 |
Why?
| | Phenylthiohydantoin | 1 | 2021 | 42 | 0.040 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2022 | 104 | 0.040 |
Why?
| | Neural Crest | 1 | 2022 | 118 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 778 | 0.040 |
Why?
| | Wnt Proteins | 1 | 2022 | 133 | 0.040 |
Why?
| | Skull | 1 | 2022 | 139 | 0.040 |
Why?
| | Precision Medicine | 1 | 2025 | 429 | 0.040 |
Why?
| | Ephrin-B2 | 1 | 2021 | 47 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2022 | 3015 | 0.040 |
Why?
| | Cartilage | 1 | 2022 | 188 | 0.040 |
Why?
| | Breast | 1 | 2021 | 151 | 0.040 |
Why?
| | Tamoxifen | 1 | 2021 | 202 | 0.040 |
Why?
| | Nitriles | 1 | 2021 | 172 | 0.040 |
Why?
| | Benzamides | 1 | 2021 | 216 | 0.040 |
Why?
| | Melanoma, Experimental | 1 | 2020 | 114 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2019 | 8 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2020 | 138 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2025 | 7635 | 0.040 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 24 | 0.040 |
Why?
| | Chondrocytes | 1 | 2022 | 212 | 0.040 |
Why?
| | beta Catenin | 1 | 2022 | 253 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 56 | 0.040 |
Why?
| | Androgens | 1 | 2021 | 187 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 171 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 13 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 13209 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 190 | 0.040 |
Why?
| | Inhibitor of Differentiation Proteins | 1 | 2018 | 2 | 0.040 |
Why?
| | Cell Cycle | 1 | 2021 | 601 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 367 | 0.040 |
Why?
| | 5-Methylcytosine | 1 | 2017 | 22 | 0.030 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 51 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2020 | 889 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1477 | 0.030 |
Why?
| | CpG Islands | 1 | 2017 | 157 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 452 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 601 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2023 | 916 | 0.030 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2017 | 67 | 0.030 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2016 | 41 | 0.030 |
Why?
| | Taxoids | 1 | 2016 | 102 | 0.030 |
Why?
| | Co-Repressor Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2016 | 155 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 2016 | 115 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1272 | 0.030 |
Why?
| | Heterografts | 1 | 2016 | 138 | 0.030 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 250 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2074 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 182 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 327 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2016 | 191 | 0.030 |
Why?
| | rhoC GTP-Binding Protein | 1 | 2014 | 6 | 0.030 |
Why?
| | Exome | 1 | 2016 | 231 | 0.030 |
Why?
| | Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 6 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2016 | 523 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2016 | 2189 | 0.030 |
Why?
| | Sequence Analysis, DNA | 2 | 2008 | 812 | 0.030 |
Why?
| | Urothelium | 1 | 2015 | 37 | 0.030 |
Why?
| | Protein Domains | 1 | 2016 | 289 | 0.030 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2014 | 56 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1325 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1502 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2009 | 2900 | 0.030 |
Why?
| | Sequence Analysis, Protein | 1 | 2014 | 30 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 257 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 366 | 0.030 |
Why?
| | Ornithine Decarboxylase | 1 | 2013 | 10 | 0.030 |
Why?
| | Follistatin | 1 | 2013 | 12 | 0.030 |
Why?
| | Eflornithine | 1 | 2013 | 6 | 0.030 |
Why?
| | Metabolomics | 1 | 2019 | 678 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2015 | 307 | 0.030 |
Why?
| | Point Mutation | 1 | 2015 | 235 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2607 | 0.030 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2014 | 34 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2014 | 225 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1226 | 0.030 |
Why?
| | Aminoglycosides | 1 | 2013 | 25 | 0.030 |
Why?
| | Area Under Curve | 1 | 2014 | 314 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 934 | 0.030 |
Why?
| | beta-Lactams | 1 | 2013 | 33 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1062 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 810 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2016 | 412 | 0.030 |
Why?
| | Organ Size | 1 | 2013 | 477 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1050 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 539 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1357 | 0.020 |
Why?
| | Genes, ras | 1 | 2012 | 97 | 0.020 |
Why?
| | Doxycycline | 1 | 2012 | 62 | 0.020 |
Why?
| | Cell Cycle Checkpoints | 1 | 2012 | 98 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2013 | 286 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2013 | 328 | 0.020 |
Why?
| | Antigens, CD | 1 | 2014 | 521 | 0.020 |
Why?
| | Quinolones | 1 | 2013 | 137 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 849 | 0.020 |
Why?
| | Benzimidazoles | 1 | 2012 | 170 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2014 | 427 | 0.020 |
Why?
| | DNA | 1 | 2017 | 1459 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2013 | 491 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1353 | 0.020 |
Why?
| | Pupa | 1 | 2009 | 10 | 0.020 |
Why?
| | Gene Library | 1 | 2009 | 118 | 0.020 |
Why?
| | Body Weight | 1 | 2013 | 985 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1120 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1738 | 0.020 |
Why?
| | Larva | 1 | 2009 | 226 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2167 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2012 | 450 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 815 | 0.020 |
Why?
| | Synteny | 1 | 2007 | 15 | 0.020 |
Why?
| | Gene Order | 1 | 2007 | 26 | 0.020 |
Why?
| | Adolescent | 2 | 2017 | 21513 | 0.020 |
Why?
| | Genome, Mitochondrial | 1 | 2007 | 27 | 0.020 |
Why?
| | Codon | 1 | 2007 | 89 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2757 | 0.020 |
Why?
| | Multigene Family | 1 | 2007 | 198 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2007 | 343 | 0.020 |
Why?
| | Immunity | 1 | 2007 | 143 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2007 | 121 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2015 | 2833 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6828 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10388 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2008 | 216 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 15657 | 0.020 |
Why?
| | RNA, Untranslated | 1 | 2007 | 124 | 0.020 |
Why?
| | Reproduction | 1 | 2007 | 204 | 0.020 |
Why?
| | Drosophila Proteins | 1 | 2007 | 204 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1724 | 0.010 |
Why?
| | Child | 1 | 2023 | 21935 | 0.010 |
Why?
| | RNA | 1 | 2008 | 921 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2008 | 4295 | 0.010 |
Why?
|
|
Costello's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|